查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1971578

不孕症治疗服务市场：按治疗类型、不孕症类型、支付方式、治疗阶段、年龄层和最终用户划分 - 全球预测 2026-2032 年

Fertility Services Market by Procedure Type, Infertility Type, Payment Type, Treatment Stage, Age Group, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，生育治疗服务市场价值将达到 514.4 亿美元，到 2026 年将成长至 556.4 亿美元，到 2032 年将达到 900.7 亿美元，复合年增长率为 8.33%。

主要市场统计数据
基准年 2025 514.4亿美元
预计年份：2026年 556.4亿美元
预测年份 2032 900.7亿美元
复合年增长率 (%) 8.33%

权威概述了新的临床创新、患者期望、供应链压力以及重塑医疗保健机构生育服务提供的策略需求。

生育服务领域正处于快速临床创新、人口结构变化以及支付方和监管动态演变的交汇点。临床实务正超越传统的体外受精（IVF）框架，而冷冻保存策略和辅助技术正在重塑医疗服务的提供方式。同时，随着患者对便利性、透明度和结果的期望日益提高，诊所和诊断检查室被迫改善通讯协定、加大数位化投入并采用实证品质指标。

对临床创新、数位转型、人口结构变化和政策趋势如何重塑生育治疗服务生态系统进行前瞻性、综合分析。

科技创新和服务模式正在推动不孕症治疗各阶段的变革。从慢速冷冻到玻璃化冷冻，冷冻保存技术的进步提高了胚胎和配子的存活率，使诊所能够制定多样化的治疗方案。同时，传统体外受精（IVF）通讯协定的改进和微刺激IVF技术的出现，使临床医生能够根据患者的年龄和不孕症状调整促排卵强度，从而优化治疗安全性和疗效。

2025 年实施的贸易政策转变和关税措施对所有生育治疗服务管道的采购韧性、临床运作和病患支付能力的影响。

2025年实施的关税及相关贸易措施为采购、临床营运和病患支付能力等各领域带来了新的、多元化的压力。对进口实验室设备、特殊耗材和低温保存组件的限制，提高了采购风险的可见度，迫使许多医疗机构和诊断检查室重新评估其供应商策略。因此，一些机构正在加快对替代供应商的认证，加强库存缓衝，并探索与本地製造伙伴关係，以保护关键临床工作流程免受供应链中断的影响。

基于深度细分的洞察突显了治疗选择、医疗保健环境、不孕症病因、支付机制、治疗顺序和年龄层如何影响临床路径和服务设计。

了解不孕症治疗全程的服务需求、临床应用和收入模式，关键在于掌握各个细分领域的动态变化。治疗层面的差异显着：冷冻保存策略分为慢速冷冻和玻璃化冷冻，其中玻璃化冷冻因其快速冷却和更高的胚胎存活率而日益受到青睐。同时，传统体外受精（IVF）和微创IVF在促排卵强度和患者耐受性方面有明显的临床权衡。卵胞浆内单一精子注射（ICSI）、子宫内人工授精（IUI）和促排卵在通讯协定选择中继续发挥不同的作用，其选择取决于不孕症的根本类型（复杂因素、女性因素、男性因素、不明原因不孕等）和患者的年龄。

区域趋势和跨境医疗保健的考虑因素正在推动全球生育市场在技术采用、监管合规、支付方互动和患者流动性方面的差异。

区域趋势对医疗服务取得模式、定价架构以及病患和服务跨境流动有显着影响。在美洲，医疗服务提供模式多种多样，从私人资助的诊所网络到影响支付方谈判和服务商品搭售的公共项目，不一而足。在这些市场中，明确的监管政策和完善的报销机制促进了先进实验室技术的应用，而自费患者对价格的高度敏感则推动了对低强度刺激通讯协定和替代治疗顺序的需求。

以产品品质、垂直整合、供应链韧性与临床教育为手段，实现差异化与市场进入的竞争与合作型企业策略。

在生育生态系统的竞争格局中，那些兼具卓越临床水准、规模优势和一体化服务模式的机构更具优势。生殖技术和耗材製造商正加大对产品品质、监管支援和培训计画的投入，以促进诊所采用先进的诊疗通讯协定。诊断服务提供者则透过检测准确性、快速出结果以及支持胚胎选择和男性因素评估的综合报告来提升自身竞争力。同时，诊所集团和医院系统正在探索垂直整合策略，将检测服务纳入内部，以加强品管并提高病患留存率。

为医疗保健提供者和供应商提供切实有效的建议，以增强供应链韧性、加快临床部署、优化支付方参与度，并扩大患者在各个护理路径中的就医途径。

领导者应优先考虑切实可行的策略，以克服复杂性并获得临床和商业性效益。首先，应实现采购管道多元化，并为关键诊断设备和一次性耗材建立双源采购系统，以降低贸易中断带来的风险。其次，应投资临床培训项目，以加速玻璃化冷冻疗法、微创体外受精通讯协定和先进诊断流程的安全实施，从而改善治疗效果和患者满意度。第三，应扩大远端医疗和数位化咨询的覆盖范围，以简化治疗前评估，提高患者依从性，并减少增加成本的非临床接触点。

一个透明的多方法研究框架，整合了专家访谈、临床文献综述和供应商评估，旨在验证检验并识别策略风险领域。

本研究途径采用定性和定量相结合的方法，以确保研究结果的严谨性和可重复性。主要资料收集包括对医疗机构的临床负责人、检查室经理和采购负责人进行结构化访谈，并辅以生殖内分泌学家和卫生经济学专家组成的专家小组的意见。次要研究包括对同侪审查的临床文献、监管指南和技术白皮书进行系统性回顾，以检验不同治疗方案和检查室工作流程的临床疗效和安全性。

它简洁地整合了创新、政策影响和策略要求，为医疗保健提供者和供应商提供了清晰的蓝图，以保护品质并扩大患者的就医途径。

生育服务正经历着一场意义深远的变革时期，其特点是临床创新、患者期望的不断变化以及营运复杂性的日益增加。冷冻保存技术的进步、体外受精通讯协定的改进以及数位化医疗模式的整合，正在重塑诊所和诊断检查室的价值创造方式。同时，外部压力，特别是贸易相关政策的变化，凸显了筹资策略和供应链韧性的重要性。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：依治疗方法分類的不孕症治疗服务市场

  • 冷冻保存
    • 慢速冷冻
    • 玻璃化冷冻
  • 体外受精
    • 常规体外受精
    • 微试管婴儿
  • 胞浆内单一精子注射（ICSI）
  • 子宫内人工授精
  • 诱导排卵

第九章：以不孕症类型分類的不孕症治疗服务市场

  • 综合因素
  • 女性因素
  • 男性因素
  • 原因不明

第十章：按支付方式分類的不孕症治疗服务市场

  • 保险范围
    • 公共保险
    • 私人保险
  • 自费
    • 雇主承担的费用
    • 自有资金

第十一章：依治疗阶段分類的不孕症治疗服务市场

  • 新鲜胚胎移植
  • 冷冻胚胎移植
    • 选择性冷冻胚胎移植
    • 冷冻胚胎移植合併药物治疗

第十二章：不孕症治疗服务市场：依年龄组别划分

  • 40岁以上
  • 35至40岁
  • 35岁以下

第十三章：不孕症治疗服务市场：依最终用户划分

  • 诊断检查室
  • 不孕症治疗诊所
  • 医院
  • 外科中心

第十四章：不孕症治疗服务市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章：不孕症治疗服务市场：依群体划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 不孕症治疗服务市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章：美国不孕症治疗服务市场

第十八章：中国不孕症治疗服务市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Bayer AG
  • Boston IVF, LLC
  • CCRM Ltd.
  • Cook Group
  • Eugin Group Holding SL
  • Extend Fertility, LLC
  • Fujifilm Holdings Corporation
  • Gedeon Richter Plc
  • Inception Fertility, LLC
  • IVI SA
  • Kindbody, Inc.
  • Monash IVF Group Limited
  • Progyny, Inc.
  • Shady Grove Fertility, LLC
Product Code: MRR-535C62918B36

The Fertility Services Market was valued at USD 51.44 billion in 2025 and is projected to grow to USD 55.64 billion in 2026, with a CAGR of 8.33%, reaching USD 90.07 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 51.44 billion
Estimated Year [2026] USD 55.64 billion
Forecast Year [2032] USD 90.07 billion
CAGR (%) 8.33%

An authoritative overview of emergent clinical innovations, patient expectations, supply chain pressures, and strategic imperatives reshaping fertility service delivery across care settings

The fertility services landscape sits at the intersection of rapid clinical innovation, shifting demographic patterns, and evolving payer and regulatory dynamics. Clinical practice is expanding beyond traditional in vitro fertilization pathways, with cryopreservation strategies and adjunctive technologies reshaping care delivery. Concurrently, patient expectations around convenience, transparency, and outcomes are prompting clinics and diagnostic laboratories to refine protocols, invest in digital engagement, and adopt evidence-based quality metrics.

These developments are unfolding against a complex backdrop of supply chain vulnerabilities and changing trade policies that influence access to specialized consumables and laboratory equipment. As a result, organizational leaders and clinical directors must balance investments in new clinical capabilities with operational resilience. The following executive summary distills the most consequential shifts, synthesizes segmentation and regional nuances, presents implications for provider and payer stakeholders, and offers pragmatic recommendations to translate insights into measurable operational improvements.

A forward-looking synthesis of clinical innovation, digital transformation, demographic change, and policy dynamics that are collectively reordering the fertility services ecosystem

Technological innovation and service delivery models are driving transformative shifts across every node of the fertility pathway. Advances in cryopreservation techniques, from slow freezing to vitrification, are increasing embryo and gamete viability and enabling clinics to diversify treatment sequencing. Simultaneously, refinements in conventional IVF protocols and the emergence of mini-IVF approaches allow clinicians to tailor stimulation intensity to patient age cohorts and infertility presentations, thereby optimizing safety and outcomes.

Parallel to clinical evolution, digital health and telemedicine are improving pre-treatment counseling, follow-up, and patient adherence, while genomic screening and precision diagnostics are refining embryo selection and male factor assessment. These shifts are altering demand patterns across diagnostic laboratories, fertility clinics, hospitals, and surgical centers, and they are influencing how payers and self-paying patients prioritize care pathways. Moreover, changing patient demographics, including delayed childbearing and evolving family structures, are increasing attention on age-stratified strategies and the relative use of fresh versus frozen embryo transfers.

Finally, regulatory and reimbursement landscapes are prompting providers to rethink pricing transparency, outcomes reporting, and partnership models with suppliers. In combination, these dynamics create both opportunity and complexity: organizations that integrate clinical innovation with operational resilience and patient-centered service models will secure competitive advantage and deliver higher perceived value.

How trade policy shifts and tariff measures enacted in 2025 are reshaping procurement resilience, clinical operations, and patient affordability across fertility care delivery channels

The implementation of tariffs and related trade measures in 2025 has introduced new and varied pressures across procurement, clinical operations, and patient affordability. Restrictions on imported laboratory instrumentation, specialized consumables, and cryogenic storage components have raised the visibility of sourcing risk, prompting many providers and diagnostic laboratories to re-evaluate vendor strategies. As a result, some organizations are accelerating qualification of alternative suppliers, increasing inventory buffers, and exploring localized manufacturing partnerships to insulate critical clinical workflows from supply chain shocks.

These trade-related frictions also influence cost structures in different care settings. Fertility clinics and surgical centers that rely on high-specification incubators, disposables, or imported reagents may encounter tighter margins or the need to adjust pricing models for self-pay patients. Hospitals and larger health systems have scope to centralize purchasing and negotiate volume-based arrangements, while standalone clinics often face more acute exposure. In parallel, payers and government insurance programs are reassessing coverage thresholds and reimbursement terms to account for shifting input costs, which can influence patient decisions between insurance-covered pathways and out-of-pocket funding options such as employer reimbursement or self-funding.

In response, leading organizations are pursuing diversified procurement, bilateral supplier agreements, and programmatic investments in supply-chain visibility. They are also refining clinical protocols to reduce dependence on single-source consumables without compromising outcomes. As policies evolve, providers that actively engage with regulators and payers to articulate the clinical implications of trade measures will be better positioned to mitigate access disruptions and preserve continuity of care.

Deep segmentation-driven insights highlighting how procedure selection, care setting, infertility etiology, payment mechanisms, treatment sequencing, and age cohorts influence clinical pathways and service design

Segment-specific dynamics are central to understanding service demand, clinical adoption, and revenue pathways across the fertility continuum. Procedure-level differentiation is pronounced: cryopreservation strategies vary between slow freezing and vitrification, with vitrification increasingly preferred for its rapid cooling profile and improved survival rates, while conventional IVF and mini-IVF present distinct clinical trade-offs between stimulation intensity and patient tolerance. Intracytoplasmic sperm injection, intrauterine insemination, and ovulation induction continue to play discrete roles in protocol selection, with choice guided by underlying infertility type-whether combined factor, female factor, male factor, or unexplained-and by patient age profile.

End-user context shapes operational design and capital allocation. Diagnostic laboratories focus on assay throughput, quality control, and rapid turnaround for genetic and semen analysis, whereas fertility clinics emphasize patient experience, cycle management, and outcomes tracking; hospitals and surgical centers integrate fertility procedures within broader perioperative and reproductive health services. Payment structures further influence patient pathways: when insurance coverage is available through government or private plans, utilization patterns differ from scenarios in which patients rely on employer reimbursement or self-funding. This interplay affects uptake of elective services such as frozen embryo transfer variants and the sequencing between fresh and frozen embryo strategies.

Age group segmentation remains a defining axis for clinical decision-making. Patients over forty typically follow alternative stimulation and transfer strategies compared with those aged thirty-five to forty or under thirty-five, with age-informed counseling shaping expectations and treatment choice. Across all segments, the most resilient providers apply stratified clinical algorithms, align reimbursement conversations early in the care pathway, and maintain flexible operational capacity to accommodate the variable demand driven by procedure type, end-user setting, infertility etiology, payment source, treatment stage, and patient age.

Regional dynamics and cross-border care considerations that drive differential technology adoption, regulatory compliance, payer interactions, and patient mobility across global fertility markets

Regional dynamics exert a strong influence on access models, pricing frameworks, and the cross-border flow of patients and services. The Americas continue to host diverse delivery models, from privately funded clinic networks to public-sector programs that shape payer negotiations and service bundling. Throughout these markets, regulatory clarity and established reimbursement channels support adoption of advanced laboratory techniques, though pricing sensitivity among self-paying patients drives demand for lower-intensity stimulation protocols and alternative treatment sequencing.

In Europe, the Middle East and Africa, regulatory heterogeneity is pronounced and cultural factors deeply inform care-seeking behavior. Several jurisdictions emphasize stringent laboratory accreditation and donor regulations, which in turn favor established clinic networks and accredited diagnostic laboratories. Concurrently, parts of the region are significant sources of medical travel, drawing patients who seek specialized protocols or more favorable legal frameworks for reproductive services.

Asia-Pacific presents a complex mosaic of rapid technology adoption, varied reimbursement models, and concentrated fertility hubs that attract international patients. Investments in laboratory capacity, a strong supplier base for reproductive technologies, and an expanding private clinic sector are notable features. Across all regions, regional policy measures, local manufacturing capacity, and the degree of payer participation in fertility benefits materially influence providers' strategic decisions related to service mix, pricing, and cross-border collaboration.

Competitive and collaborative company strategies emphasizing product quality, vertical integration, supply-chain resilience, and clinical education as levers of differentiation and market access

Competitive dynamics in the fertility ecosystem favor organizations that combine clinical excellence with operational scale and integrated service offerings. Manufacturers of reproductive technologies and consumables are investing in product quality, regulatory support, and training programs to facilitate clinic adoption of advanced protocols. Diagnostic providers are differentiating through assay precision, rapid result delivery, and integrated reporting that supports embryo selection and male factor assessment. Concurrently, clinic groups and hospital systems are exploring vertical integration strategies that bring laboratory services in-house to enhance quality control and patient retention.

Strategic partnerships and targeted investments are common themes: collaborations between device manufacturers and clinical networks help accelerate adoption of new techniques while reducing training friction. Service providers that embed digital patient engagement platforms and outcomes measurement frameworks secure higher retention and better-informed consent processes. At the same time, distribution and logistics partners that offer cold-chain reliability and responsive replenishment play a critical role in preserving clinical continuity, particularly where supply chain disruptions or tariff-induced constraints raise operational risk. Overall, the most adaptive organizations combine product innovation, clinical education, and supply-chain resilience to sustain competitive advantage.

Practical, high-impact recommendations for providers and suppliers to build supply resilience, accelerate clinical adoption, optimize payer engagement, and expand patient access across care pathways

Leaders should prioritize a set of actionable strategies to navigate complexity and capture clinical and commercial upside. First, diversify procurement channels and formalize dual-sourcing arrangements for critical laboratory equipment and single-use consumables to reduce exposure to trade disruptions. Second, invest in clinical training programs that accelerate safe adoption of vitrification, mini-IVF protocols, and advanced diagnostic workflows, thereby improving outcomes and patient satisfaction. Third, expand telemedicine and digital counseling to streamline pre-treatment assessment, increase patient adherence, and reduce nonclinical touchpoints that add cost.

Further, engage proactively with payers and benefit managers to craft coverage pathways that reflect the value of evidence-based protocols and to explore bundled payment models that align clinical incentives. Strengthen data capture and outcomes reporting to support reimbursement discussions and to enable continuous quality improvement. From an organizational perspective, consider regional partnerships or joint ventures to enter markets with complex regulatory or logistical barriers. Finally, develop patient-centric pricing and financing options-such as staged payment plans, employer reimbursement navigation, and outcome-based agreements-to broaden access and manage affordability concerns while preserving clinical standards.

A transparent, multi-method research framework integrating primary expert interviews, clinical literature review, and supplier assessments to validate insights and identify strategic risk areas

The research approach combined qualitative and quantitative methods to ensure rigorous and reproducible findings. Primary data collection included structured interviews with clinical leaders, laboratory directors, and procurement executives across care settings, complemented by expert panels with reproductive endocrinologists and health economics specialists. Secondary research encompassed a systematic review of peer-reviewed clinical literature, regulatory guidance, and technology white papers to validate clinical efficacy and safety profiles for procedural variations and laboratory workflows.

Analytical triangulation synthesized interview insights, clinical evidence, and supplier assessments to identify consistent patterns and to surface risk areas such as supply-chain exposure and payer sensitivity. The methodology emphasized transparency in data sources and limitations, documenting assumptions underlying segmentation analysis and flagging areas where evolving policy or clinical evidence could alter operational conclusions. Ethical considerations included anonymization of interview data and adherence to professional standards for clinical reporting, ensuring that recommendations are grounded in robust evidence and stakeholder experience.

A concise synthesis of innovation, policy impact, and strategic imperatives offering a clear roadmap for providers and suppliers to safeguard quality and expand patient access

Fertility services are undergoing a period of substantive change characterized by clinical innovation, evolving patient expectations, and greater operational complexity. Advances in cryopreservation, refinements in IVF protocols, and the integration of digital care models are reshaping how clinics and diagnostic laboratories deliver value. At the same time, external pressures-particularly trade-related policy shifts-are elevating the importance of procurement strategy and supply-chain resilience.

Strategic clarity emerges from segmentation-aware planning, regional sensitivity, and proactive payer engagement. Providers and suppliers that implement diversified sourcing, invest in clinician training, and adopt robust outcomes measurement will be better positioned to navigate uncertainty and to capture growth in patient demand. The recommendations summarized here provide a practical roadmap to translate insights into operational actions that preserve quality, improve access, and strengthen the financial sustainability of fertility service delivery.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Fertility Services Market, by Procedure Type

  • 8.1. Cryopreservation
    • 8.1.1. Slow Freezing
    • 8.1.2. Vitrification
  • 8.2. In Vitro Fertilization
    • 8.2.1. Conventional IVF
    • 8.2.2. Mini IVF
  • 8.3. Intracytoplasmic Sperm Injection
  • 8.4. Intrauterine Insemination
  • 8.5. Ovulation Induction

9. Fertility Services Market, by Infertility Type

  • 9.1. Combined Factor
  • 9.2. Female Factor
  • 9.3. Male Factor
  • 9.4. Unexplained

10. Fertility Services Market, by Payment Type

  • 10.1. Insurance Coverage
    • 10.1.1. Government Insurance
    • 10.1.2. Private Insurance
  • 10.2. Out Of Pocket
    • 10.2.1. Employer Reimbursement
    • 10.2.2. Self Funding

11. Fertility Services Market, by Treatment Stage

  • 11.1. Fresh Embryo Transfer
  • 11.2. Frozen Embryo Transfer
    • 11.2.1. Elective Frozen Embryo Transfer
    • 11.2.2. Medicated Frozen Embryo Transfer

12. Fertility Services Market, by Age Group

  • 12.1. Over Forty
  • 12.2. Thirty Five To Forty
  • 12.3. Under Thirty Five

13. Fertility Services Market, by End User

  • 13.1. Diagnostic Laboratories
  • 13.2. Fertility Clinics
  • 13.3. Hospitals
  • 13.4. Surgical Centers

14. Fertility Services Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Fertility Services Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Fertility Services Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Fertility Services Market

18. China Fertility Services Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Bayer AG
  • 19.6. Boston IVF, LLC
  • 19.7. CCRM Ltd.
  • 19.8. Cook Group
  • 19.9. Eugin Group Holding S.L.
  • 19.10. Extend Fertility, LLC
  • 19.11. Fujifilm Holdings Corporation
  • 19.12. Gedeon Richter Plc
  • 19.13. Inception Fertility, LLC
  • 19.14. IVI S.A.
  • 19.15. Kindbody, Inc.
  • 19.16. Monash IVF Group Limited
  • 19.17. Progyny, Inc.
  • 19.18. Shady Grove Fertility, LLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL FERTILITY SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL FERTILITY SERVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL FERTILITY SERVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL FERTILITY SERVICES MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL FERTILITY SERVICES MARKET SIZE, BY INFERTILITY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL FERTILITY SERVICES MARKET SIZE, BY PAYMENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL FERTILITY SERVICES MARKET SIZE, BY TREATMENT STAGE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL FERTILITY SERVICES MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL FERTILITY SERVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL FERTILITY SERVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL FERTILITY SERVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL FERTILITY SERVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES FERTILITY SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA FERTILITY SERVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL FERTILITY SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL FERTILITY SERVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL FERTILITY SERVICES MARKET SIZE, BY CRYOPRESERVATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL FERTILITY SERVICES MARKET SIZE, BY CRYOPRESERVATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL FERTILITY SERVICES MARKET SIZE, BY CRYOPRESERVATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL FERTILITY SERVICES MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL FERTILITY SERVICES MARKET SIZE, BY SLOW FREEZING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL FERTILITY SERVICES MARKET SIZE, BY SLOW FREEZING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL FERTILITY SERVICES MARKET SIZE, BY SLOW FREEZING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL FERTILITY SERVICES MARKET SIZE, BY VITRIFICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL FERTILITY SERVICES MARKET SIZE, BY VITRIFICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL FERTILITY SERVICES MARKET SIZE, BY VITRIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL FERTILITY SERVICES MARKET SIZE, BY IN VITRO FERTILIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL FERTILITY SERVICES MARKET SIZE, BY IN VITRO FERTILIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL FERTILITY SERVICES MARKET SIZE, BY IN VITRO FERTILIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL FERTILITY SERVICES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL FERTILITY SERVICES MARKET SIZE, BY CONVENTIONAL IVF, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL FERTILITY SERVICES MARKET SIZE, BY CONVENTIONAL IVF, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL FERTILITY SERVICES MARKET SIZE, BY CONVENTIONAL IVF, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL FERTILITY SERVICES MARKET SIZE, BY MINI IVF, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL FERTILITY SERVICES MARKET SIZE, BY MINI IVF, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL FERTILITY SERVICES MARKET SIZE, BY MINI IVF, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL FERTILITY SERVICES MARKET SIZE, BY INTRACYTOPLASMIC SPERM INJECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL FERTILITY SERVICES MARKET SIZE, BY INTRACYTOPLASMIC SPERM INJECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL FERTILITY SERVICES MARKET SIZE, BY INTRACYTOPLASMIC SPERM INJECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL FERTILITY SERVICES MARKET SIZE, BY INTRAUTERINE INSEMINATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL FERTILITY SERVICES MARKET SIZE, BY INTRAUTERINE INSEMINATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL FERTILITY SERVICES MARKET SIZE, BY INTRAUTERINE INSEMINATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL FERTILITY SERVICES MARKET SIZE, BY OVULATION INDUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL FERTILITY SERVICES MARKET SIZE, BY OVULATION INDUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL FERTILITY SERVICES MARKET SIZE, BY OVULATION INDUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL FERTILITY SERVICES MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL FERTILITY SERVICES MARKET SIZE, BY COMBINED FACTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL FERTILITY SERVICES MARKET SIZE, BY COMBINED FACTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL FERTILITY SERVICES MARKET SIZE, BY COMBINED FACTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL FERTILITY SERVICES MARKET SIZE, BY FEMALE FACTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL FERTILITY SERVICES MARKET SIZE, BY FEMALE FACTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL FERTILITY SERVICES MARKET SIZE, BY FEMALE FACTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL FERTILITY SERVICES MARKET SIZE, BY MALE FACTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL FERTILITY SERVICES MARKET SIZE, BY MALE FACTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL FERTILITY SERVICES MARKET SIZE, BY MALE FACTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL FERTILITY SERVICES MARKET SIZE, BY UNEXPLAINED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL FERTILITY SERVICES MARKET SIZE, BY UNEXPLAINED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL FERTILITY SERVICES MARKET SIZE, BY UNEXPLAINED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL FERTILITY SERVICES MARKET SIZE, BY PAYMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL FERTILITY SERVICES MARKET SIZE, BY INSURANCE COVERAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL FERTILITY SERVICES MARKET SIZE, BY INSURANCE COVERAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL FERTILITY SERVICES MARKET SIZE, BY INSURANCE COVERAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL FERTILITY SERVICES MARKET SIZE, BY INSURANCE COVERAGE, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL FERTILITY SERVICES MARKET SIZE, BY GOVERNMENT INSURANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL FERTILITY SERVICES MARKET SIZE, BY GOVERNMENT INSURANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL FERTILITY SERVICES MARKET SIZE, BY GOVERNMENT INSURANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL FERTILITY SERVICES MARKET SIZE, BY PRIVATE INSURANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL FERTILITY SERVICES MARKET SIZE, BY PRIVATE INSURANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL FERTILITY SERVICES MARKET SIZE, BY PRIVATE INSURANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL FERTILITY SERVICES MARKET SIZE, BY OUT OF POCKET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL FERTILITY SERVICES MARKET SIZE, BY OUT OF POCKET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL FERTILITY SERVICES MARKET SIZE, BY OUT OF POCKET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL FERTILITY SERVICES MARKET SIZE, BY OUT OF POCKET, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL FERTILITY SERVICES MARKET SIZE, BY EMPLOYER REIMBURSEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL FERTILITY SERVICES MARKET SIZE, BY EMPLOYER REIMBURSEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL FERTILITY SERVICES MARKET SIZE, BY EMPLOYER REIMBURSEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL FERTILITY SERVICES MARKET SIZE, BY SELF FUNDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL FERTILITY SERVICES MARKET SIZE, BY SELF FUNDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL FERTILITY SERVICES MARKET SIZE, BY SELF FUNDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL FERTILITY SERVICES MARKET SIZE, BY TREATMENT STAGE, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL FERTILITY SERVICES MARKET SIZE, BY FRESH EMBRYO TRANSFER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL FERTILITY SERVICES MARKET SIZE, BY FRESH EMBRYO TRANSFER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL FERTILITY SERVICES MARKET SIZE, BY FRESH EMBRYO TRANSFER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL FERTILITY SERVICES MARKET SIZE, BY FROZEN EMBRYO TRANSFER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL FERTILITY SERVICES MARKET SIZE, BY FROZEN EMBRYO TRANSFER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL FERTILITY SERVICES MARKET SIZE, BY FROZEN EMBRYO TRANSFER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL FERTILITY SERVICES MARKET SIZE, BY FROZEN EMBRYO TRANSFER, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL FERTILITY SERVICES MARKET SIZE, BY ELECTIVE FROZEN EMBRYO TRANSFER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL FERTILITY SERVICES MARKET SIZE, BY ELECTIVE FROZEN EMBRYO TRANSFER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL FERTILITY SERVICES MARKET SIZE, BY ELECTIVE FROZEN EMBRYO TRANSFER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL FERTILITY SERVICES MARKET SIZE, BY MEDICATED FROZEN EMBRYO TRANSFER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL FERTILITY SERVICES MARKET SIZE, BY MEDICATED FROZEN EMBRYO TRANSFER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL FERTILITY SERVICES MARKET SIZE, BY MEDICATED FROZEN EMBRYO TRANSFER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL FERTILITY SERVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL FERTILITY SERVICES MARKET SIZE, BY OVER FORTY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL FERTILITY SERVICES MARKET SIZE, BY OVER FORTY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL FERTILITY SERVICES MARKET SIZE, BY OVER FORTY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL FERTILITY SERVICES MARKET SIZE, BY THIRTY FIVE TO FORTY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL FERTILITY SERVICES MARKET SIZE, BY THIRTY FIVE TO FORTY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL FERTILITY SERVICES MARKET SIZE, BY THIRTY FIVE TO FORTY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL FERTILITY SERVICES MARKET SIZE, BY UNDER THIRTY FIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL FERTILITY SERVICES MARKET SIZE, BY UNDER THIRTY FIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL FERTILITY SERVICES MARKET SIZE, BY UNDER THIRTY FIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL FERTILITY SERVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL FERTILITY SERVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL FERTILITY SERVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL FERTILITY SERVICES MARKET SIZE, BY FERTILITY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL FERTILITY SERVICES MARKET SIZE, BY FERTILITY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL FERTILITY SERVICES MARKET SIZE, BY FERTILITY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL FERTILITY SERVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL FERTILITY SERVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL FERTILITY SERVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL FERTILITY SERVICES MARKET SIZE, BY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL FERTILITY SERVICES MARKET SIZE, BY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL FERTILITY SERVICES MARKET SIZE, BY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL FERTILITY SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS FERTILITY SERVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS FERTILITY SERVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS FERTILITY SERVICES MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS FERTILITY SERVICES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS FERTILITY SERVICES MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS FERTILITY SERVICES MARKET SIZE, BY PAYMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS FERTILITY SERVICES MARKET SIZE, BY INSURANCE COVERAGE, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS FERTILITY SERVICES MARKET SIZE, BY OUT OF POCKET, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS FERTILITY SERVICES MARKET SIZE, BY TREATMENT STAGE, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS FERTILITY SERVICES MARKET SIZE, BY FROZEN EMBRYO TRANSFER, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS FERTILITY SERVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA FERTILITY SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA FERTILITY SERVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA FERTILITY SERVICES MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA FERTILITY SERVICES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA FERTILITY SERVICES MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA FERTILITY SERVICES MARKET SIZE, BY PAYMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA FERTILITY SERVICES MARKET SIZE, BY INSURANCE COVERAGE, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA FERTILITY SERVICES MARKET SIZE, BY OUT OF POCKET, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA FERTILITY SERVICES MARKET SIZE, BY TREATMENT STAGE, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA FERTILITY SERVICES MARKET SIZE, BY FROZEN EMBRYO TRANSFER, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA FERTILITY SERVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA FERTILITY SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA FERTILITY SERVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA FERTILITY SERVICES MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA FERTILITY SERVICES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA FERTILITY SERVICES MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA FERTILITY SERVICES MARKET SIZE, BY PAYMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA FERTILITY SERVICES MARKET SIZE, BY INSURANCE COVERAGE, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA FERTILITY SERVICES MARKET SIZE, BY OUT OF POCKET, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA FERTILITY SERVICES MARKET SIZE, BY TREATMENT STAGE, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA FERTILITY SERVICES MARKET SIZE, BY FROZEN EMBRYO TRANSFER, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA FERTILITY SERVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA FERTILITY SERVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA FERTILITY SERVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA FERTILITY SERVICES MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA FERTILITY SERVICES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA FERTILITY SERVICES MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA FERTILITY SERVICES MARKET SIZE, BY PAYMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA FERTILITY SERVICES MARKET SIZE, BY INSURANCE COVERAGE, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA FERTILITY SERVICES MARKET SIZE, BY OUT OF POCKET, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA FERTILITY SERVICES MARKET SIZE, BY TREATMENT STAGE, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA FERTILITY SERVICES MARKET SIZE, BY FROZEN EMBRYO TRANSFER, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA FERTILITY SERVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE FERTILITY SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE FERTILITY SERVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE FERTILITY SERVICES MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE FERTILITY SERVICES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE FERTILITY SERVICES MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE FERTILITY SERVICES MARKET SIZE, BY PAYMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE FERTILITY SERVICES MARKET SIZE, BY INSURANCE COVERAGE, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE FERTILITY SERVICES MARKET SIZE, BY OUT OF POCKET, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE FERTILITY SERVICES MARKET SIZE, BY TREATMENT STAGE, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE FERTILITY SERVICES MARKET SIZE, BY FROZEN EMBRYO TRANSFER, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE FERTILITY SERVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST FERTILITY SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST FERTILITY SERVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST FERTILITY SERVICES MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST FERTILITY SERVICES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST FERTILITY SERVICES MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST FERTILITY SERVICES MARKET SIZE, BY PAYMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST FERTILITY SERVICES MARKET SIZE, BY INSURANCE COVERAGE, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST FERTILITY SERVICES MARKET SIZE, BY OUT OF POCKET, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST FERTILITY SERVICES MARKET SIZE, BY TREATMENT STAGE, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST FERTILITY SERVICES MARKET SIZE, BY FROZEN EMBRYO TRANSFER, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST FERTILITY SERVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA FERTILITY SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA FERTILITY SERVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA FERTILITY SERVICES MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA FERTILITY SERVICES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA FERTILITY SERVICES MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA FERTILITY SERVICES MARKET SIZE, BY PAYMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA FERTILITY SERVICES MARKET SIZE, BY INSURANCE COVERAGE, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA FERTILITY SERVICES MARKET SIZE, BY OUT OF POCKET, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA FERTILITY SERVICES MARKET SIZE, BY TREATMENT STAGE, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA FERTILITY SERVICES MARKET SIZE, BY FROZEN EMBRYO TRANSFER, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA FERTILITY SERVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC FERTILITY SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC FERTILITY SERVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC FERTILITY SERVICES MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC FERTILITY SERVICES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC FERTILITY SERVICES MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC FERTILITY SERVICES MARKET SIZE, BY PAYMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC FERTILITY SERVICES MARKET SIZE, BY INSURANCE COVERAGE, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC FERTILITY SERVICES MARKET SIZE, BY OUT OF POCKET, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC FERTILITY SERVICES MARKET SIZE, BY TREATMENT STAGE, 2018-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC FERTILITY SERVICES MARKET SIZE, BY FROZEN EMBRYO TRANSFER, 2018-2032 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC FERTILITY SERVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. GLOBAL FERTILITY SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN FERTILITY SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN FERTILITY SERVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN FERTILITY SERVICES MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN FERTILITY SERVICES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN FERTILITY SERVICES MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN FERTILITY SERVICES MARKET SIZE, BY PAYMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN FERTILITY SERVICES MARKET SIZE, BY INSURANCE COVERAGE, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN FERTILITY SERVICES MARKET SIZE, BY OUT OF POCKET, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN FERTILITY SERVICES MARKET SIZE, BY TREATMENT STAGE, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN FERTILITY SERVICES MARKET SIZE, BY FROZEN EMBRYO TRANSFER, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN FERTILITY SERVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 212. ASEAN FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. GCC FERTILITY SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. GCC FERTILITY SERVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. GCC FERTILITY SERVICES MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 216. GCC FERTILITY SERVICES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 217. GCC FERTILITY SERVICES MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. GCC FERTILITY SERVICES MARKET SIZE, BY PAYMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. GCC FERTILITY SERVICES MARKET SIZE, BY INSURANCE COVERAGE, 2018-2032 (USD MILLION)
  • TABLE 220. GCC FERTILITY SERVICES MARKET SIZE, BY OUT OF POCKET, 2018-2032 (USD MILLION)
  • TABLE 221. GCC FERTILITY SERVICES MARKET SIZE, BY TREATMENT STAGE, 2018-2032 (USD MILLION)
  • TABLE 222. GCC FERTILITY SERVICES MARKET SIZE, BY FROZEN EMBRYO TRANSFER, 2018-2032 (USD MILLION)
  • TABLE 223. GCC FERTILITY SERVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 224. GCC FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION FERTILITY SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION FERTILITY SERVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION FERTILITY SERVICES MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION FERTILITY SERVICES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION FERTILITY SERVICES MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION FERTILITY SERVICES MARKET SIZE, BY PAYMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION FERTILITY SERVICES MARKET SIZE, BY INSURANCE COVERAGE, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPEAN UNION FERTILITY SERVICES MARKET SIZE, BY OUT OF POCKET, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION FERTILITY SERVICES MARKET SIZE, BY TREATMENT STAGE, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPEAN UNION FERTILITY SERVICES MARKET SIZE, BY FROZEN EMBRYO TRANSFER, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPEAN UNION FERTILITY SERVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPEAN UNION FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS FERTILITY SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS FERTILITY SERVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS FERTILITY SERVICES MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS FERTILITY SERVICES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS FERTILITY SERVICES MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. BRICS FERTILITY SERVICES MARKET SIZE, BY PAYMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS FERTILITY SERVICES MARKET SIZE, BY INSURANCE COVERAGE, 2018-2032 (USD MILLION)
  • TABLE 244. BRICS FERTILITY SERVICES MARKET SIZE, BY OUT OF POCKET, 2018-2032 (USD MILLION)
  • TABLE 245. BRICS FERTILITY SERVICES MARKET SIZE, BY TREATMENT STAGE, 2018-2032 (USD MILLION)
  • TABLE 246. BRICS FERTILITY SERVICES MARKET SIZE, BY FROZEN EMBRYO TRANSFER, 2018-2032 (USD MILLION)
  • TABLE 247. BRICS FERTILITY SERVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 248. BRICS FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 249. G7 FERTILITY SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 250. G7 FERTILITY SERVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. G7 FERTILITY SERVICES MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 252. G7 FERTILITY SERVICES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 253. G7 FERTILITY SERVICES MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. G7 FERTILITY SERVICES MARKET SIZE, BY PAYMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. G7 FERTILITY SERVICES MARKET SIZE, BY INSURANCE COVERAGE, 2018-2032 (USD MILLION)
  • TABLE 256. G7 FERTILITY SERVICES MARKET SIZE, BY OUT OF POCKET, 2018-2032 (USD MILLION)
  • TABLE 257. G7 FERTILITY SERVICES MARKET SIZE, BY TREATMENT STAGE, 2018-2032 (USD MILLION)
  • TABLE 258. G7 FERTILITY SERVICES MARKET SIZE, BY FROZEN EMBRYO TRANSFER, 2018-2032 (USD MILLION)
  • TABLE 259. G7 FERTILITY SERVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 260. G7 FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 261. NATO FERTILITY SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 262. NATO FERTILITY SERVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. NATO FERTILITY SERVICES MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 264. NATO FERTILITY SERVICES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 265. NATO FERTILITY SERVICES MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. NATO FERTILITY SERVICES MARKET SIZE, BY PAYMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. NATO FERTILITY SERVICES MARKET SIZE, BY INSURANCE COVERAGE, 2018-2032 (USD MILLION)
  • TABLE 268. NATO FERTILITY SERVICES MARKET SIZE, BY OUT OF POCKET, 2018-2032 (USD MILLION)
  • TABLE 269. NATO FERTILITY SERVICES MARKET SIZE, BY TREATMENT STAGE, 2018-2032 (USD MILLION)
  • TABLE 270. NATO FERTILITY SERVICES MARKET SIZE, BY FROZEN EMBRYO TRANSFER, 2018-2032 (USD MILLION)
  • TABLE 271. NATO FERTILITY SERVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 272. NATO FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 273. GLOBAL FERTILITY SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED STATES FERTILITY SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED STATES FERTILITY SERVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED STATES FERTILITY SERVICES MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 277. UNITED STATES FERTILITY SERVICES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED STATES FERTILITY SERVICES MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 279. UNITED STATES FERTILITY SERVICES MARKET SIZE, BY PAYMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 280. UNITED STATES FERTILITY SERVICES MARKET SIZE, BY INSURANCE COVERAGE, 2018-2032 (USD MILLION)
  • TABLE 281. UNITED STATES FERTILITY SERVICES MARKET SIZE, BY OUT OF POCKET, 2018-2032 (USD MILLION)
  • TABLE 282. UNITED STATES FERTILITY SERVICES MARKET SIZE, BY TREATMENT STAGE, 2018-2032 (USD MILLION)
  • TABLE 283. UNITED STATES FERTILITY SERVICES MARKET SIZE, BY FROZEN EMBRYO TRANSFER, 2018-2032 (USD MILLION)
  • TABLE 284. UNITED STATES FERTILITY SERVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 285. UNITED STATES FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 286. CHINA FERTILITY SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 287. CHINA FERTILITY SERVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 288. CHINA FERTILITY SERVICES MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 289. CHINA FERTILITY SERVICES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
  • TABLE 290. CHINA FERTILITY SERVICES MARKET SIZE, BY INFERTILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 291. CHINA FERTILITY SERVICES MARKET SIZE, BY PAYMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 292. CHINA FERTILITY SERVICES MARKET SIZE, BY INSURANCE COVERAGE, 2018-2032 (USD MILLION)
  • TABLE 293. CHINA FERTILITY SERVICES MARKET SIZE, BY OUT OF POCKET, 2018-2032 (USD MILLION)
  • TABLE 294. CHINA FERTILITY SERVICES MARKET SIZE, BY TREATMENT STAGE, 2018-2032 (USD MILLION)
  • TABLE 295. CHINA FERTILITY SERVICES MARKET SIZE, BY FROZEN EMBRYO TRANSFER, 2018-2032 (USD MILLION)
  • TABLE 296. CHINA FERTILITY SERVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 297. CHINA FERTILITY SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)